Anne L. Holleran

Array ( [id] => 5284425 [patent_doc_number] => 20090098100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Hormonally up-regulated, neu-tumor-associated kinase' [patent_app_type] => utility [patent_app_number] => 12/082026 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28768 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098100.pdf [firstpage_image] =>[orig_patent_app_number] => 12082026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289925 [patent_doc_number] => 20100158914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'KLOTHO BETA' [patent_app_type] => utility [patent_app_number] => 12/594443 [patent_app_country] => US [patent_app_date] => 2008-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 61439 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158914.pdf [firstpage_image] =>[orig_patent_app_number] => 12594443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280060 [patent_doc_number] => 20100119457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'COMPOSITION OF LABELED AND NON-LABELED MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/593621 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11578 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119457.pdf [firstpage_image] =>[orig_patent_app_number] => 12593621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415870 [patent_doc_number] => 20090041757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Bone morphogenetic protein antagonist and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/075944 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15099 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041757.pdf [firstpage_image] =>[orig_patent_app_number] => 12075944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545401 [patent_doc_number] => 20090155278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Claudins as Markers for Early Detection, Diagnosis, Prognosis and as Targets of Therapy for Breast and Metastatic Brain or Bone Cancer' [patent_app_type] => utility [patent_app_number] => 12/044031 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15714 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155278.pdf [firstpage_image] =>[orig_patent_app_number] => 12044031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638116 [patent_doc_number] => 20100173918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'METHODS AND COMPOSITIONS FOR DETERMINING THE EFFICACY OF BREAST CANCER THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 12/529115 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7270 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173918.pdf [firstpage_image] =>[orig_patent_app_number] => 12529115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4926982 [patent_doc_number] => 20080166345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3' [patent_app_type] => utility [patent_app_number] => 12/033516 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26855 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166345.pdf [firstpage_image] =>[orig_patent_app_number] => 12033516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7761748 [patent_doc_number] => 08114606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'ARL-1 specific antibodies' [patent_app_type] => utility [patent_app_number] => 12/032327 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 19208 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114606.pdf [firstpage_image] =>[orig_patent_app_number] => 12032327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535016 [patent_doc_number] => 08048640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Methods for evaluating and implementing prostate disease treatments' [patent_app_type] => utility [patent_app_number] => 12/011929 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 13392 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048640.pdf [firstpage_image] =>[orig_patent_app_number] => 12011929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726592 [patent_doc_number] => 20080206133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Cancerous Disease Modifying Antibodies' [patent_app_type] => utility [patent_app_number] => 12/017886 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17324 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206133.pdf [firstpage_image] =>[orig_patent_app_number] => 12017886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720317 [patent_doc_number] => 20080242840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'NOVEL INHIBITORS OF ANGIOGENESIS AND TUMOR GROWTH' [patent_app_type] => utility [patent_app_number] => 11/971112 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19900 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242840.pdf [firstpage_image] =>[orig_patent_app_number] => 11971112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954509 [patent_doc_number] => 20080187533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'TREATMENT WITH ANTI-ERBB2 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/969465 [patent_app_country] => US [patent_app_date] => 2008-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17534 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187533.pdf [firstpage_image] =>[orig_patent_app_number] => 11969465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6313660 [patent_doc_number] => 20100111851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'DIAGNOSIS AND TREATMENT OF CANCER BY USING ANTI-PRG-3 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/448715 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30369 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111851.pdf [firstpage_image] =>[orig_patent_app_number] => 12448715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322946 [patent_doc_number] => 20090060936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Ii-Key/Her-2/neu hybrid cancer vaccine' [patent_app_type] => utility [patent_app_number] => 12/002083 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9239 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060936.pdf [firstpage_image] =>[orig_patent_app_number] => 12002083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728170 [patent_doc_number] => 20080207714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Diagnosis And Treatment Of Breast Cancer' [patent_app_type] => utility [patent_app_number] => 11/936871 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25628 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207714.pdf [firstpage_image] =>[orig_patent_app_number] => 11936871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833927 [patent_doc_number] => 20080132474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'BREAST CANCER SCREENING AND TREATMENT METHODS' [patent_app_type] => utility [patent_app_number] => 11/935870 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18163 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132474.pdf [firstpage_image] =>[orig_patent_app_number] => 11935870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758883 [patent_doc_number] => 20080311109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 11/929835 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38633 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311109.pdf [firstpage_image] =>[orig_patent_app_number] => 11929835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751953 [patent_doc_number] => 20080160026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Apo-2 ligand-anti-her-2 antibody synergism' [patent_app_type] => utility [patent_app_number] => 11/978038 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14822 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160026.pdf [firstpage_image] =>[orig_patent_app_number] => 11978038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718624 [patent_doc_number] => 20080241146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Apo-2 ligand-anti-Her-2 antibody synergism' [patent_app_type] => utility [patent_app_number] => 11/978018 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14821 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241146.pdf [firstpage_image] =>[orig_patent_app_number] => 11978018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702637 [patent_doc_number] => 08088390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Methods for the early diagnosis of ovarian cancer' [patent_app_type] => utility [patent_app_number] => 11/973468 [patent_app_country] => US [patent_app_date] => 2007-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 37 [patent_no_of_words] => 13955 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088390.pdf [firstpage_image] =>[orig_patent_app_number] => 11973468 [rel_patent_id] =>[rel_patent_doc_number] =>)